According to FutureWise analysis the market for immuno-oncology in 2023 is US$ 101.4 billion, and is expected to reach US$ 240 billion by 2031 at a CAGR of 12%.
Cancer immunotherapy, also known as immuno-oncology, is a way of treating cancer by employing the body's own immune system to stop, eliminate, and control the disease. By boosting your immune system, giving your body more components to boost the immunological response, and teaching your body to recognise and fight particular cancer cells, it can also aid in the elimination of cancer. In cancer immunotherapy, a number of therapies are available, such as targeted antibodies, cancer vaccines, adoptive cell transfer, tumour-infecting viruses, checkpoint inhibitors, cytokines, and adjuvants. Immunotherapies are a type of biotherapy (also known as biologic therapy or biological response modifier (BRM) therapy), which uses compounds from living organisms to treat disease.
The Department of Immuno-Oncology is at the forefront of medical research that uses the body's immune system to combat cancer. Due to its potential to utilise the body's built-in immunity to infection, immunotherapy is a significant tool against cancer. T-cell treatment, which employs specialised immune system cells to target and eliminate cancer cells, and immune checkpoint blockade, which modifies or strengthens the immune system to attack and eradicate tumour cells, are two cancer immunotherapies now in use. For some people with metastatic cancer, these treatments work. But, researchers in the Department of Immuno-Oncology envision immunotherapy playing a much more significant role in the fight against cancer. By making immunotherapy a very effective first-line treatment option that can result in more potent, less toxic treatments, scientists hope to advance immunotherapy to the front lines. In order to treat patients with early-stage cancer and remove the microscopic residual disease that might cause cancer to return even after chemotherapy, radiation therapy, and surgery have been successful, researchers are aiming to further improve the effectiveness of these innovative medicines.
FutureWise Market Research has published a report that provides an insightful analysis of Immuno-oncology market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the Immuno-oncology market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.